{"quoteSummary":{"result":[{"defaultKeyStatistics":{"maxAge":1,"priceHint":{"raw":2,"fmt":"2","longFmt":"2"},"enterpriseValue":{"raw":74969536,"fmt":"74.97M","longFmt":"74,969,536"},"forwardPE":{},"profitMargins":{"raw":0.04685,"fmt":"4.68%"},"floatShares":{"raw":3172524,"fmt":"3.17M","longFmt":"3,172,524"},"sharesOutstanding":{"raw":5071700,"fmt":"5.07M","longFmt":"5,071,700"},"sharesShort":{},"sharesShortPriorMonth":{},"heldPercentInsiders":{},"heldPercentInstitutions":{},"shortRatio":{},"shortPercentOfFloat":{},"beta":{"raw":0.194373,"fmt":"0.19"},"morningStarOverallRating":{},"morningStarRiskRating":{},"category":null,"bookValue":{"raw":13.397,"fmt":"13.40"},"priceToBook":{"raw":0.8292901,"fmt":"0.83"},"annualReportExpenseRatio":{},"ytdReturn":{},"beta3Year":{},"totalAssets":{},"yield":{},"fundFamily":null,"fundInceptionDate":{},"legalType":null,"threeYearAverageReturn":{},"fiveYearAverageReturn":{},"priceToSalesTrailing12Months":{},"lastFiscalYearEnd":{"raw":1490918400,"fmt":"2017-03-31"},"nextFiscalYearEnd":{"raw":1553990400,"fmt":"2019-03-31"},"mostRecentQuarter":{"raw":1514678400,"fmt":"2017-12-31"},"earningsQuarterlyGrowth":{},"revenueQuarterlyGrowth":{},"netIncomeToCommon":{"raw":6594060,"fmt":"6.59M","longFmt":"6,594,060"},"trailingEps":{"raw":1.3,"fmt":"1.30"},"forwardEps":{},"pegRatio":{},"lastSplitFactor":null,"lastSplitDate":{},"enterpriseToRevenue":{"raw":0.533,"fmt":"0.53"},"enterpriseToEbitda":{"raw":11.217,"fmt":"11.22"},"52WeekChange":{"raw":-0.19931513,"fmt":"-19.93%"},"SandP52WeekChange":{"raw":0.12668931,"fmt":"12.67%"},"lastDividendValue":{},"lastCapGain":{},"annualHoldingsTurnover":{}},"summaryProfile":{"address1":"133, Kanchan Bagh","address2":"Ground Floor","city":"Indore","zip":"452001","country":"India","phone":"91 73 1396 1510","website":"http://www.beryldrugs.com","industry":"Drugs - Generic","sector":"Healthcare","longBusinessSummary":"Beryl Drugs Limited manufactures and markets branded and generic pharmaceutical formulations in India. The company offers I.V. fluids and small volume injectables, as well as veterinary products. It also provides research and development, and contract manufacturing services. The company offers its products through a sales and distribution network. Beryl Drugs Limited was founded in 1993 and is based in Indore, India.","companyOfficers":[],"maxAge":86400},"financialData":{"maxAge":86400,"currentPrice":{"raw":11.11,"fmt":"11.11"},"targetHighPrice":{},"targetLowPrice":{},"targetMeanPrice":{},"targetMedianPrice":{},"recommendationMean":{},"recommendationKey":"none","numberOfAnalystOpinions":{},"totalCash":{"raw":7528000,"fmt":"7.53M","longFmt":"7,528,000"},"totalCashPerShare":{"raw":1.485,"fmt":"1.49"},"ebitda":{"raw":6683439,"fmt":"6.68M","longFmt":"6,683,439"},"totalDebt":{"raw":15532000,"fmt":"15.53M","longFmt":"15,532,000"},"quickRatio":{},"currentRatio":{},"totalRevenue":{"raw":140746352,"fmt":"140.75M","longFmt":"140,746,352"},"debtToEquity":{"raw":19.116,"fmt":"19.12"},"revenuePerShare":{"raw":27.74,"fmt":"27.74"},"returnOnAssets":{},"returnOnEquity":{},"grossProfits":{"raw":40729488,"fmt":"40.73M","longFmt":"40,729,488"},"freeCashflow":{},"operatingCashflow":{},"earningsGrowth":{},"revenueGrowth":{"raw":0.41,"fmt":"41.00%"},"grossMargins":{"raw":0.35608003,"fmt":"35.61%"},"ebitdaMargins":{"raw":0.047480002,"fmt":"4.75%"},"operatingMargins":{"raw":0.02239,"fmt":"2.24%"},"profitMargins":{"raw":0.04685,"fmt":"4.68%"},"financialCurrency":"INR"}}],"error":null}}